, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Dyfed. And, I suppose, an important question to you, Dyfed: how confident are you that cancer data that you do share with partners, and the Welsh Government especially, is actually leading to policy change or spending priority differences?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Joyce. Just to give you a bit of advance notice of my last question, I wanted just to ask you both if there's anything else you think is useful to impart to us in our work that's not been drawn out through questions? I'll come to you in a moment…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Dyfed.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
I can see Helen wants to come in as well. Shall I bring Helen in first? Helen.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Gareth. Joyce Watson.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Dyfed, sorry to interrupt you, there's a slight technical issue with the translation, so I'm just going to ask you to pause for a moment and ask the translation if they can undertake a test. [TRANSLATION: Testing interpretation. This is the interpreter…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Yes. Thank you, Helen. Just to give some indication, we've probably got about 10 minutes, Gareth, for your section and 10 minutes for your section, Joyce, or just under 10 minutes. So, Gareth Davies.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Lovely. Thanks, Mabon. Helen, when do you expect the roll-out of CaNISC to be completed?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Just before I come back to Mabon, I'm just conscious we're halfway through the meeting, but we haven't got halfway through the questions that we've got. So, I hate to ask this because, of course, we want as much detail as possible, but just bear that in mind…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Mabon, Joyce wanted to come in. Do you mind Joyce coming in now? Yes. And then I'll come back to you. Joyce.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Sarah. Mabon ap Gwynfor.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Did you want to add, briefly, to that, Dyfed?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Who's answering? Is that to Helen?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Dyfed.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Dyfed, I'll bring you in if you want to comment on either of those questions.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Dyfed.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Helen, do you want to come in? There we are.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Dyfed. Sarah Murphy.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
So, just to help me understand, if you have collected data and you've carried out analysis of that data, it sounds like you don't always publish it—is that right?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
That's helpful. I suppose it would be good to know who sets the priorities for what data you do publish and what data you analyse. Who sets that?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Dyfed, that's really helpful. In terms of my opening comments, I think our evidence has been published in terms of the Wales Cancer Alliance, but we'll ask the team to get that from our public website, and send you a link to that, so you can see—
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, both, for being with us this morning. I know you've both indicated that you're happy to be called 'Dyfed' and 'Helen', so thank you for that. There's a common theme across much of our work when it comes to data, or the lack of data—it's a common…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
Thank you, Dyfed. And Helen Thomas.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
In that case, I move to item 2, and this is our seventh evidence session for the committee's inquiry into gynaecological cancers, and will be hearing, in this session, from representatives from the Welsh Cancer Surveillance Intelligence Unit—that's a…
, Health and Social Care Committee
Introductions, apologies, substitutions and declarations of interest
Bore da. Croeso, pawb. Welcome to the Health and Social Care Committee this morning. As always, our meetings are bilingual, and we're operating in a hybrid format today. I move to item 1, and we have apologies this morning from Jack Sargeant and Rhun ap…
